AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi market portfolio of over , , square feet of sustainable cannabis production infrastructure in various stages of development. AmeriCann s team includes experts in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development. To support local businesses that seek to serve cannabis patients in their communities we initiated the AmeriCann Preferred Partner Program. Through this program we provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner s businesses. In addition, AmeriCann s team has been instrumental in winning cannabis licenses in competitive application processes throughout the country. This support is designed to assist our Preferred Partners in newly regulated markets. AmeriCann leases facilities to our Preferred Partners that are designed with AmeriCann s propriety cultivation and processing system called Cannopy. AmeriCann developed Cannopy with experts from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation. Cannopy includes automation throughout the production life cycle, customized workflow processes, monitoring and controls, and top line security systems. Cannopy empowers Preferred Partners to consistently produce medical marijuana for patients at the lowest cost in the most efficient, compliant manner. We provide initial and on going training, policies, practices and procedures to operate the state of the art facilities. The expanding cannabis industry requires extensive real estate to meet the growing needs of patients. AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. AmeriCann assists our Preferred Partners with the identification, design, permitting, acquisition, development and operation of scalable infrastructure to cultivate and to dispense medical marijuana in regulated markets. As an early market participant, the Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands. More information about the Company is available at https://americann.co
Quote | Americann Inc (OTCMKTS:ACAN)
Last: | $0.061 |
---|---|
Change Percent: | 0.0% |
Open: | $0.068 |
Close: | $0.061 |
High: | $0.068 |
Low: | $0.061 |
Volume: | 600 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Americann Inc (OTCMKTS:ACAN)
The Company achieved its best-ever annual revenue and net income for its latest four quarters DENVER, CO / ACCESSWIRE / May 16, 2023 / (via IBN) AmeriCann Inc. (OTCQB:ACAN) (the "Company"), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution ...
AmeriCann Inc. (OTCQB: ACAN) reported its financial and operational results for the quarter ending December 2022. Revenue increased by approximately 13% to $734,766 for the quarter and net income increased by $555,773. The company also delivered a net income of $22,745 versus last year...
Message Board Posts | Americann Inc (OTCMKTS:ACAN)
Subject | By | Source | When |
---|---|---|---|
It is worth a goose egg equity wise. | diduknow | investorshub | 04/11/2022 10:57:19 PM |
No new preferred partners, no signs of expansion, | 420Hope | investorshub | 04/11/2022 3:26:07 PM |
When will this company replace Keough with a | 420Hope | investorshub | 04/06/2022 11:08:16 AM |
Any signs of life here? When the other | 420Hope | investorshub | 03/14/2022 3:18:36 PM |
Matters not at this point, stick a fork | diduknow | investorshub | 11/22/2021 4:44:39 PM |
News, Short Squeeze, Breakout and More Instantly...
The Company achieved its best-ever annual revenue and net income for its latest four quarters DENVER, CO / ACCESSWIRE / May 16, 2023 / (via IBN) AmeriCann Inc. (OTCQB:ACAN) (the "Company"), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution ...
AmeriCann Inc. (OTCQB: ACAN) reported its financial and operational results for the quarter ending December 2022. Revenue increased by approximately 13% to $734,766 for the quarter and net income increased by $555,773. The company also delivered a net income of $22,745 versus last year...
DENVER, Feb. 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, has released financial and operational results for its quarte...